Association Between Plasma Levels of Monocyte Chemoattractant Protein-1 (MCP-1) and 28-Day Mortality in Elderly Patients with Sepsis: A Retrospective Single-Center Study
Open Access
- 14 November 2023
- journal article
- research article
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 29, e942079-e942079-8
Abstract
Background: Previous studies have identified an association between plasma levels of the inflammatory cytokine, monocyte chemoattractant protein-1 (MCP-1), and outcomes for patients with sepsis. This retrospective single-center study assessed the association between plasma levels of MCP-1 and 28-day mortality in 136 patients 365 years diagnosed with sepsis between October 2020 and October 2021. Material/Methods: The objective was to compare and analyze the parameters in the survival group (n=35) and the 28-day mortality group (n=101), including Sequential Organ Failure Assessment (SOFA), Acute Physiology and Chronic Health Evaluation II (APACHE II), plasma MCP-1, and laboratory test results. Plasma MCP-1 was quantified by cytokine test kit (LKTM014B, R&D). Statistical analysis was carried out in SPSS 26.0 and MedCalc 92.1.0 software. Results: The 28-day mortality group exhibited higher levels of SOFA, APACHEII, and plasma MCP-1 (all P<0.001), as well as lower levels of albumin, compared to the survival group (P<0.05). The logistic regression analysis findings indicated that SOFA, APACHEII, plasma MCP-1, and SBP are all independent risk factors for 28-day mortality. The area under the curve for SOFA, APACHEII, MCP-1, MCP-1+ SOFA, and MCP-1+APACHEII were 0.845, 0.744, 0.712, 0.879, and 0.822, respectively. MCP-1+SOFA exhibited higher sensitivity than SOFA alone. Furthermore, the assessment values of plasma MCP-1 combined with SOFA were superior to those of APACHE II or plasma MCP-1 (Z1=2.661, Z2=3.272, both P<0.01). Conclusions: The findings from this study from a single center support those of previous studies that increased plasma levels of MCP-1 are significantly associated with 28-day mortality in patients with sepsis.Keywords
This publication has 50 references indexed in Scilit:
- Lactate and Immunosuppression in SepsisShock, 2018
- Monocyte chemoattractant protein 1 released from macrophages induced by hepatitis C virus promotes monocytes migrationVirus Research, 2017
- Cardioprotective effects of irbesartan in polymicrobial sepsisHerz, 2017
- Plasma Monocyte Chemoattractant Protein 1 as a Predictive Marker for Sepsis Prognosis: A Prospective Cohort StudyThe Tohoku Journal of Experimental Medicine, 2017
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA, 2016
- Prognostic significance of APACHE II score and plasma suPAR in Chinese patients with sepsis: a prospective observational studyBMC Anesthesiology, 2015
- Sepsis-Surviving Mice Are More Susceptible to a Secondary Kidney Insult*Critical Care Medicine, 2013
- Inflammation, Endoplasmic Reticulum Stress, Autophagy, and the Monocyte Chemoattractant Protein-1/CCR2 PathwayCirculation Research, 2012
- Monocyte chemoattractant protein-1 and paraoxonase-1 and 3 levels in patients with sepsis treated in an intensive care unit: a preliminary reportClinical Chemistry and Laboratory Medicine (CCLM), 2012
- Important Role for CC Chemokine Ligand 2-Dependent Lung Mononuclear Phagocyte Recruitment to Inhibit Sepsis in Mice Infected with Streptococcus pneumoniae ,The Journal of Immunology, 2009